1. Exploration of some indole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents
   Tran Thi Lan Huong et al, 2017, Chem. Pap. CrossRef
2. Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling
   Samuel Bouchet et al, 2019, ACS Med. Chem. Lett. CrossRef
3. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice
   Sylvain Lamoine et al, 2021, IJMS CrossRef
4. Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis
   Kaitlyn E. Collins et al, 2023, Front. Endocrinol. CrossRef
5. Myeloid-associated differentiation marker is associated with type 2 asthma and is upregulated by human rhinovirus infection
   Sasipa Tanyaratsrisakul et al, 2023, Front. Immunol. CrossRef
6. Enhancing MS‐275 Anticancer Activity: Encapsulation of MS‐275 in TPGS Micelles Demonstrated High Efficiency
   Abdulelah S. Alshawli et al, 2024, Journal of Nanotechnology CrossRef